Wed, Oct 22, 2014, 4:19 AM EDT - U.S. Markets open in 5 hrs 11 mins

Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • ghosttraderg ghosttraderg Nov 17, 2011 3:48 PM Flag

    Corporate Presentation – November 2011

    Investment Highlights
     New AmiKet™ data in CIPN
    • Breakthrough efficacy in disease with high unmet medical
    need
    • Partnership discussions ongoing
    • EOP2 Meeting with FDA scheduled for December 2011
     Ceplene® approved in EU, launched in UK, Germany, Italy and
    Austria
    • Additional reimbursement filings in Spain, France and
    remainder of key approved countries in 2011
     Key investigator initiated trial strategy underway
     New Ceplene® US 4
    Phase III survival trial required for US filing


    http://investor.epicept.com/index.cfm

 
IMNP
2.95-0.07(-2.32%)Oct 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.